Table 1.
Variables | Survivors n=151 | Comparison group n=7910 | p-value | ||
---|---|---|---|---|---|
Gender | n | % | n | % | |
Male | 78 | 51.7 | 3982 | 50.3 | NS |
Female | 73 | 48.3 | 3928 | 49.7 | |
Age at assessment (years) | NS | ||||
Mean (SD) | 16 | (1.7) | 16 | (1.5) | |
Diagnosis | n | % | |||
AML | 34 | 22.5 | |||
IA | 37 | 24.5 | |||
WT | 80 | 53.0 | |||
Age at diagnosis (years) | |||||
Mean (SD) | 5.5 | (2.9) | |||
AML | 6.5 | (3.4) | |||
IA | 6.2 | (2.9) | 0.003 | ||
WT | 4.8 | (2.4) | |||
Time since diagnosis (years) | |||||
Mean (SD) | 10 | (3.2) | |||
AML | 9.12 | (3.7) | |||
IA | 10.0 | (3.4) | NS | ||
WT | 10.9 | (2.8) | |||
Treatment | n | ||||
Chemotherapy | 13 | ||||
Chemotherapy, surgery | 55 | ||||
Chemotherapy, radiation, surgery | 22 | ||||
Radiation, surgery | 4 | ||||
Surgery | 31 | ||||
Stem cell transplantation | 22 | ||||
Unknown | 4 |
AML, acute myeloid leukemia; IA, infratentorial astrocytoma; NS, not significant; SD, standard deviation; WT, Wilms tumor.